Negative or normal serum tests included coagulation panel Vitamin B3, Vitamin B12, methylmalonic acid, homocysteine, lead, mercury, thallium, arsenic, HIV, RPR hepatitis B/C serologies, Lyme, Bartonella, SPEP/UPEP, rheumatoid factor, anti-double-stranded DNA antibodies, anti-neutrophil cytoplasmic antibodies, anti-citric citrullinated peptide antibodies, anti-gliadin antibodies, anti-endomysial antibodies, cryoglobulins, anti-smith antibodies, anti-ribonucleoprotein antibodies, Sjogrens antibodies, IgG subclasses, IgE, complement C3 and C4 levels, angiotensin-converting enzyme, mitochondrial antibodies, GAD-65 autoantibodies, anti-GM1/2 antibodies, GQ1B antibodies, and Gd1a/b antibodies
Here are the vectors of innovation that players are currently focused on: GLP-1 innovation vector (1): Drug design and formulation Next-generation molecules aim to improve both efficacy and convenience
Anaesthesiol ., 34 (3), 479491
Bottom line: Self-injection is a safe and effective way to deliver GLP-1 therapy when performed with care and consistency
And even the tiny amount that survived would face the intestinal epithelial barrier, a wall of tightly packed cells that peptides of this molecular weight cannot easily cross
